Reneo Pharmaceuticals Inc (RPHM)
1.72
+0.06
(+3.61%)
USD |
NASDAQ |
May 17, 16:00
1.70
-0.02
(-1.16%)
Pre-Market: 20:00
Reneo Pharmaceuticals Shareholders Equity (Quarterly): 81.24M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 81.24M |
| December 31, 2023 | 88.61M |
| September 30, 2023 | 114.94M |
| June 30, 2023 | 132.53M |
| March 31, 2023 | 87.08M |
| December 31, 2022 | 99.97M |
| September 30, 2022 | 112.04M |
| Date | Value |
|---|---|
| June 30, 2022 | 124.16M |
| March 31, 2022 | 135.32M |
| December 31, 2021 | 147.21M |
| September 30, 2021 | 156.21M |
| June 30, 2021 | 167.55M |
| March 31, 2021 | -48.72M |
| December 31, 2020 | -42.12M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-48.72M
Minimum
Mar 2021
167.55M
Maximum
Jun 2021
96.86M
Average
113.49M
Median
Shareholders Equity (Quarterly) Benchmarks
| Mirum Pharmaceuticals Inc | 234.60M |
| NovaBay Pharmaceuticals Inc | 0.16M |
| Palatin Technologies Inc | 1.579M |
| iBio Inc | 9.197M |
| Theriva Biologics Inc | 34.12M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 84.64M |
| Total Liabilities (Quarterly) | 3.397M |